Aerie Pharmaceuticals names new COO

NJBIZ STAFF//August 6, 2013//

Listen to this article

Bedminster-based Aerie Pharmaceuticals Inc. announced Monday it has named Thomas Mitro president and chief operating officer. Mitro’s appointment is effective immediately.

According to the company, prior to joining Aerie, Mitro most recently served as vice president of sales and marketing at Omeros Corp., a publicly traded clinical-stage biopharmaceutical company. He was also vice president for sales and marketing at ISTA Pharmaceuticals.

Aerie named new chief executive Vicente Anido Jr. in July.

Digital content editor Joe Ross is @joeross on Twitter.